The medication's primary mechanisms of action include: Enhanced insulin secretion : Stimulates pancreatic beta cells to release insulin in response to elevated blood glucose Reduced glucagon release : Suppresses inappropriate glucagon secretion from pancreatic alpha cells Delayed gastric emptying : Slows food transit from the stomach, promoting satiety (though this effect may diminish over time) Central appetite regulation : Acts on brain centers to reduce hunger and food intake Improved metabolic function : Weight loss from tirzepatide contributes to improved insulin sensitivity Regarding water retention specifically, fluid retention is not listed as a characteristic adverse effect of tirzepatide in FDA prescribing information or major clinical trials
If hiccups bother you, trial small, specific changes while tracking each variable precisely: meal size and composition, carbonated beverages, alcohol, timing relative to injection, dose escalation dates, and injection site
The binding of GLP-1RA to GLP-1R activates adenyl cyclase, which facilitates the conversion of ATP to cAMP
Both compounds have benefits that have been proven by science, but each has its own unique benefits for different uses